US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist
  • 24.120
  • +0.270+1.13%
Trading Dec 11 11:13 ET
844.17MMarket Cap-63.47P/E (TTM)

Oruka Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
Operating revenue
--0
--0
Cost of revenue
Gross profit
Operating expense
29.45M
21.49M
Selling and administrative expenses
--3.76M
--2.82M
-General and administrative expense
--3.76M
--2.82M
Research and development costs
--25.69M
--18.67M
Operating profit
-29.45M
-21.49M
Net non-operating interest income expense
826K
-750K
Non-operating interest income
--1.33M
----
Non-operating interest expense
--504K
--750K
Other net income (expense)
Income before tax
-28.62M
-22.24M
Income tax
Net income
-28.62M
-22.24M
Net income continuous Operations
---28.62M
---22.24M
Minority interest income
Net income attributable to the parent company
-28.62M
-22.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.62M
-22.24M
Basic earnings per share
-1.46
-0.7566
Diluted earnings per share
-1.46
-0.7566
Dividend per share
Currency Unit
USD
USD
Accounting Standards
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 00
Operating revenue --0--0
Cost of revenue
Gross profit
Operating expense 29.45M21.49M
Selling and administrative expenses --3.76M--2.82M
-General and administrative expense --3.76M--2.82M
Research and development costs --25.69M--18.67M
Operating profit -29.45M-21.49M
Net non-operating interest income expense 826K-750K
Non-operating interest income --1.33M----
Non-operating interest expense --504K--750K
Other net income (expense)
Income before tax -28.62M-22.24M
Income tax
Net income -28.62M-22.24M
Net income continuous Operations ---28.62M---22.24M
Minority interest income
Net income attributable to the parent company -28.62M-22.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.62M-22.24M
Basic earnings per share -1.46-0.7566
Diluted earnings per share -1.46-0.7566
Dividend per share
Currency Unit USDUSD
Accounting Standards US-GAAPUS-GAAP
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.